Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906344-09-000256
Filing Date
2009-02-11
Accepted
2009-02-11 17:23:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G-A2 (2-11-09) pluristemtherapeutics_13g-a1.htm SC 13G/A 60535
  Complete submission text file 0000906344-09-000256.txt   62703
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Subject) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-78785 | Film No.: 09590759
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 415.677.1577
Enable Capital Management, LLC (Filed by) CIK: 0001383071 (see all company filings)

EIN.: 731625368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A